The Advisor

January 09, 2018

Ontario's OHIP+ program takes effect

As of January 1, Ontario’s OHIP+ program took effect, providing free prescription drug coverage for individuals 24 and under for medicines listed in...

Read More

RECEIVE THE ADVISOR

December 12, 2016

Inflectra being approved for Crohn's Disease and Colitis under provincial plans

Pfizer's Inflectra, a subsequent entry biologic drug for indications similar to those for Remicade, has recently been approved for new starts for such indications as Crohn's Disease and Ulcerative Colitis in several provinces, with the other...

Read More
December 12, 2016

Accompass sponsoring Dr. Danielle Martin's January 26 book launch

Read More
December 12, 2016

January 1 EI Waiting Period Changes and What They Mean For Employers

Read More